Skip to main content
Figure 4 | BMC Medicine

Figure 4

From: Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

Figure 4

Results of the entire study group. Prevalence of ALR, CLR and Dual LR before and after modification according to the therapy algorithm (without prasugrel) Percentage of dual responder (Responder), clopidogrel low responder (CLR), ASA low responder (ALR) and dual low responder (Dual LR) before and after optimization of antiplatelet therapy. Note: By applying the therapy algorithm (without prasugrel), the low responder rate can be reduced absolute by 36.1% (relative -86.6%) and including prasugrel low response was eliminated.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us